PMID- 35578895 OWN - NLM STAT- MEDLINE DCOM- 20220801 LR - 20220902 IS - 1460-2091 (Electronic) IS - 0305-7453 (Linking) VI - 77 IP - 8 DP - 2022 Jul 28 TI - In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence. PG - 2183-2190 LID - 10.1093/jac/dkac155 [doi] AB - BACKGROUND: Bacterial vaginosis (BV), the most common cause of vaginal discharge, is characterized by the presence of a polymicrobial biofilm on the vaginal epithelium, formed primarily by Gardnerella spp., but also other anaerobic species. Interactions between bacteria in multi-species biofilms are likely to contribute to increased virulence and to enhanced antimicrobial tolerance observed in vivo. However, functional studies addressing this question are lacking. OBJECTIVES: To gain insights into the role that interactions between BV-associated species in multi-species BV biofilms might have on antimicrobial tolerance, single- and triple-species biofilms formed by Gardnerella vaginalis, Fannyhessea (Atopobium) vaginae and Peptostreptococcus anaerobius were characterized, before and after metronidazole or clindamycin treatment. METHODS: Total biofilm biomass, total cells and cfu counts prior to and after antibiotic treatment were first determined. In addition, bacterial populations in the triple-species biofilms were also quantified by quantitative PCR (qPCR) and peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH). RESULTS: Despite the effect observed in single-species biofilms, neither metronidazole nor clindamycin was effective in reducing triple-species biofilm biomass. Similar results were obtained when evaluating the number of total or culturable cells. Interestingly, despite differences between strain susceptibilities to antibiotics, the composition of the triple-species biofilms was not strongly affected by antibiotics. CONCLUSIONS: Taken together, these results strengthen the idea that, when co-incubated, bacteria can interact synergistically, leading to increased tolerance to antimicrobial therapy, which helps explain the observed clinically high BV recurrence rates. CI - (c) The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Rosca, Aliona S AU - Rosca AS AD - Laboratory of Research in Biofilms Rosario Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. AD - Laboratory of Bacteriology Research (LBR), Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium. FAU - Castro, Joana AU - Castro J AD - Laboratory of Research in Biofilms Rosario Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. FAU - Sousa, Lucia G V AU - Sousa LGV AD - Laboratory of Research in Biofilms Rosario Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. AD - LABBELS - Associate Laboratory, Braga/Guimaraes, Portugal. FAU - Franca, Angela AU - Franca A AUID- ORCID: 0000-0001-7117-6837 AD - Laboratory of Research in Biofilms Rosario Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. AD - LABBELS - Associate Laboratory, Braga/Guimaraes, Portugal. FAU - Vaneechoutte, Mario AU - Vaneechoutte M AD - Laboratory of Bacteriology Research (LBR), Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium. FAU - Cerca, Nuno AU - Cerca N AUID- ORCID: 0000-0003-3365-3537 AD - Laboratory of Research in Biofilms Rosario Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. AD - LABBELS - Associate Laboratory, Braga/Guimaraes, Portugal. LA - eng GR - Portuguese Foundation for Science and Technology/ GR - PTDC/BIA-MIC/28271/2017/FCT/ PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Antimicrob Chemother JT - The Journal of antimicrobial chemotherapy JID - 7513617 RN - 0 (Anti-Bacterial Agents) RN - 0 (Anti-Infective Agents) RN - 140QMO216E (Metronidazole) RN - 3U02EL437C (Clindamycin) RN - Atopobium vaginae SB - IM MH - Actinobacteria MH - Anti-Bacterial Agents/pharmacology MH - *Anti-Infective Agents MH - Bacteria MH - Biofilms MH - Clindamycin/pharmacology MH - Female MH - Gardnerella vaginalis/genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Metronidazole/pharmacology MH - Vagina/microbiology MH - *Vaginosis, Bacterial/microbiology EDAT- 2022/05/18 06:00 MHDA- 2022/08/02 06:00 CRDT- 2022/05/17 03:54 PHST- 2021/12/01 00:00 [received] PHST- 2022/04/22 00:00 [accepted] PHST- 2022/05/18 06:00 [pubmed] PHST- 2022/08/02 06:00 [medline] PHST- 2022/05/17 03:54 [entrez] AID - 6586622 [pii] AID - 10.1093/jac/dkac155 [doi] PST - ppublish SO - J Antimicrob Chemother. 2022 Jul 28;77(8):2183-2190. doi: 10.1093/jac/dkac155.